Size Increment During Surveillance in Papillary Thyroid Cancer: Evidence Synthesis and Dose–Response Meta‐Analysis
<h3>Introduction</h3><p dir="ltr">Differentiated thyroid cancer has become a prevalent malignant tumor, particularly papillary thyroid carcinoma (PTC), constituting over 90% of cases. Most PTC lesions are asymptomatic and remain subclinical throughout life, and active sur...
Saved in:
| Main Author: | Mohamed Badie Ahmed (10223510) (author) |
|---|---|
| Other Authors: | Emad Naem (21363605) (author), Harman Saman (16316283) (author), Abeer Alsherawi (17945291) (author), Asma Syed (14778826) (author), Noora Al‐Abdulla (22502162) (author), Latifa Alkaabi (22502165) (author), Mahmoud A. Zirie (19421317) (author), Suhail A. Doi (9552474) (author) |
| Published: |
2025
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chronic myeloid leukemia following low dose radioactive iodine (I<sup>131</sup>) for treatment of papillary thyroid cancer
by: Yousef Mohammed Ali Hailan (14777536)
Published: (2022) -
Papillary Thyroid Carcinoma with Fibromatosis/Fasciitis-Like/Desmoid-Type Stroma: Case Report of a Rare Subtype with Cytological and Molecular Study
by: Hosamadean Benghashir (22224895)
Published: (2024) -
Evaluation Of Anti Thyroid Activity of Cannabis Sativa Oil Extract Against Levothyroxine Induced Hyperthyroidism in Mice
by: Al Sayed, Dania
Published: (2021) -
CAR-T cell therapy: Efficacy in management of cancers, adverse effects, dose-limiting toxicities and long-term follow up
by: Mohamed Elmarasi (14614276)
Published: (2024) -
Clinical versus fixed warfarin dosing and the impact on quality of anticoagulation (The ClinFix trial)
by: Amr M. Fahmi (21632909)
Published: (2024)